Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial.
Saved in:
| Title: | Exhaled volatile organic compounds and lung microbiome in COPD: a pilot randomised controlled trial. |
|---|---|
| Authors: | Mohan D; GSK R&D, Collegeville, PA, USA., Keir HR; Ninewells Clinical Research Centre, University of Dundee, Dundee, UK., Richardson H; Ninewells Clinical Research Centre, University of Dundee, Dundee, UK., Mayhew D; GSK R&D, Collegeville, PA, USA., Boyer J; GSK R&D, Collegeville, PA, USA., van der Schee MP; Owlstone Medical, Cambridge, UK., Allsworth MD; Owlstone Medical, Cambridge, UK., Miller BE; GSK R&D, Collegeville, PA, USA., Tal-Singer R; GSK R&D, Collegeville, PA, USA., Chalmers JD; Ninewells Clinical Research Centre, University of Dundee, Dundee, UK. |
| Source: | ERJ open research [ERJ Open Res] 2021 Oct 04; Vol. 7 (4). Date of Electronic Publication: 2021 Oct 04 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2312-0541 |
|---|---|
| DOI: | 10.1183/23120541.00253-2021 |
